Daily Stock Analysis, CGIX, Cancer Genetics Inc, priceseries

Cancer Genetics Inc. Daily Stock Analysis
Stock Information
Open
1.75
Close
1.85
High
1.90
Low
1.75
Previous Close
1.70
Daily Price Gain
0.15
YTD High
1.95
YTD High Date
Jan 11, 2017
YTD Low
1.35
YTD Low Date
Jan 5, 2017
YTD Price Change
0.45
YTD Gain
32.14%
52 Week High
3.35
52 Week High Date
Mar 22, 2016
52 Week Low
1.10
52 Week Low Date
Nov 4, 2016
52 Week Price Change
-0.19
52 Week Gain
-9.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 17. 2015
7.59
Mar 2. 2015
8.38
9 Trading Days
10.41%
Link
LONG
Apr 9. 2015
8.78
Apr 22. 2015
9.51
9 Trading Days
8.37%
Link
LONG
Mar 17. 2016
2.57
Mar 24. 2016
2.73
5 Trading Days
6.42%
Link
LONG
Aug 12. 2016
2.17
Aug 29. 2016
2.29
11 Trading Days
5.42%
Link
LONG
Nov 9. 2016
1.35
Nov 25. 2016
1.61
11 Trading Days
19.11%
Link
Company Information
Stock Symbol
CGIX
Exchange
NasdaqCM
Company URL
http://www.cancergenetics.com
Company Phone
201.528.9200
CEO
Panna L. Sharma
Headquarters
New Jersey
Business Address
201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD, NJ 07070
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001349929
About

Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by ...

Description

Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company's clinical services provide information on diagnosis, prognosis, and predicting treatment outcomes of cancers to guide patient management. Its biopharma services offer companies with customized solutions for patient stratification and treatment selection through a suite of molecular- and biomarker-based testing services, customized assay development, and trial design consultation. The company's discovery services provide the tools and testing methods for companies and researchers to identify new molecular-based biomarkers for disease. It serves hospitals, cancer centers, clinics, researchers, and academic institutions, as well as biopharma and biotech companies performing clinical trials. Cancer Genetics, Inc. was founded in 1999 and is headquartered in Rutherford, New Jersey.